Goal Commitment and Proactive Health Behavior in Chronic Disease Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45+
SponsorXiong Juyang
About this trial
Chronic diseases such as hypertension, diabetes, and dyslipidemia are major contributors to mortality and healthcare burden worldwide. Despite high awareness of health risks, many patients fail to adopt proactive health behaviors due to behavioral inertia and a gap between knowledge and action.
This study aims to investigate the evolution and driving mechanisms of proactive health behavior in patients with chronic diseases based on goal commitment theory. By integrating prospect theory and evolutionary game theory, this study will explore how behavioral strategies evolve under different levels of goal commitment.
In addition, a behavioral intervention based on the Stimulus-Organism-Response (SOR) model will be developed to enhance patient activation and promote adherence to proactive health behaviors. A parallel controlled intervention study will be conducted to evaluate the effectiveness of the goal commitment-based intervention.
The findings of this study are expected to provide theoretical and practical evidence to improve chronic disease management and promote proactive health behaviors.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Residents living in the study area for at least 1.5 years
Diagnosed with at least one chronic disease, including hypertension, diabetes mellitus, or dyslipidemia
Conscious and able to communicate effectively
Educational level of primary school or above
Disqualifiers
Non-residents of the study area
Unable to participate in group-based intervention activities
Currently hospitalized
Diagnosed with severe cognitive impairment, dementia, or psychiatric disorders
Trial design
Design model
Parallel
Treatments tested in this trial
Goal Commitment-Based Behavioral Intervention
BehavioralThis intervention is a structured behavioral program based on goal commitment theory, designed to promote proactive health behaviors in patients with chronic diseases. The intervention includes goal setting, personalized action planning, behavioral activation, and continuous follow-up support. Participants will receive guidance to enhance motivation, strengthen commitment to health goals, and improve adherence to chronic disease management through regular monitoring and feedback.
Usual Care
Other interventionParticipants in the control group will receive routine chronic disease management or standard health education without additional structured behavioral intervention.
Treatment groups
600 Participants
are divided into 2 treatment groupsGroup A: Goal Commitment Intervention GroupExperimental treatment 1 intervention
Group B: Usual Care Control GroupActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Change in Proactive Health Behavior Score
The primary outcome is the difference in the mean change of proactive health behavior scores between the intervention group and the control group at 6 months after the intervention. Proactive health behaviors will be assessed using a validated Proactive Health Behavior Scale, including overall score and component scores.
Time frame
Baseline to 6 months after interventionSecondary outcomes
1
Change in Metabolic Syndrome (MetS) Score
The primary outcome includes the difference in the mean change of metabolic syndrome (MetS) scores between the intervention group and the control group at 6 months after the intervention.
Time frame
Baseline to 6 months after intervention2
Change in Proactive Health Behavior Score at 3 Months
The difference in the mean change of proactive health behavior scores and its component domains between the intervention group and the control group at 3 months after the intervention.
Time frame
Baseline to 3 months after intervention3
Change in Fasting Blood Glucose (FBG) at 3 Months
The difference in the mean change of fasting blood glucose levels between the intervention group and the control group at 3 months after the intervention.
Time frame
Baseline to 3 months after intervention4
Change in Fasting Blood Glucose (FBG)
Changes in fasting blood glucose levels measured by blood tests.
Time frame
Baseline, 3 months, and 6 months after interventionSponsors and contacts
Click on the lead sponsor to view all of their trials.
Xiong Juyang
Lead sponsor
Huazhong University of Science and Technology
Sponsor institution
Source ClinicalTrials.gov